SUPERIOR 303 NC LAW AND RULES FINAL
EXAM SCRIPT 2026 QUESTIONS AND
ANSWERS ALREADY PASSED
● May a pharmacy that services a nursing home install an automated
dispensing device (e.g., Pyxis) to dispense controlled substances at the
nursing home? Answer: In May 2005, the DEA promulgated a rule that
allows, where state law permits, a retail pharmacy to install an
automated dispensing system at a long term care facility. These systems
allow dispensing of single dosage controlled-substance units, and can
mitigate the problem of excess controlled-substance stocks and disposal.
Under Board rules, an automated dispensing device may only be
installed at a facility holding a pharmacy permit. It is the consensus of
the Board that limited service permits may be obtained for the
installation of automated dispensing systems in long term care facilities.
The DEA rule, found at 21 C.F.R. § 1301.17(c) and § 1301.27, provides
that, upon receiving authorization from appropriate state authorities, a
pharmacy may apply for an additional DEA registration to operate the
automated dispensing system at a long term care facility. Pharmacists
who serve long term care facilities are encouraged to investigate the use
of automated dispensing systems. The potential public health and safety
benefits are significant.
,● I would like to attend a Board meeting. When do Board meetings
occur? Answer: The Board of Pharmacy meets at 9 am the third Tuesday
of each month, except for August and December. If a meeting has to be
rescheduled, notice will appear on the Board's website.
● Is it permissible to compound domperidone? Answer: Domperidone
compounding is permissible only as part of an investigational new drug
application (IND). Domperidone is not a drug approved for human use
in the United States. Accordingly, any domperidone product dispensed in
the United States outside of an IND is unapproved, adulterated and
misbranded under both federal and North Carolina law. Notwithstanding
misleading Internet information to the contrary, it is not legal in the
United States to acquire, compound, dispense, or administer
domperidone outside of an IND. The FDA has long provided clear
guidance on this point, which may be found here:
http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm073
070.htm
● Has the FDA taken action against pharmacies that compound "bio-
identical hormone replacement" products? Answer: Yes
● Must a prescription label state the drug's generic name? Answer: Rule
.1818 provides that prescription labels shall contain the generic name of
the drug even if the brand name is in the container. The purpose of this
rule is to make it possible for hospital personnel to easily identify
products from the labels on prescription containers that may arrive with
,the patient in the emergency department. For example, a prescription for
Cordarone could be labeled as "Cordarone (Amiodarone)" if the brand
name was dispensed. If the generic was dispensed the label would only
need to contain the word "Amiodarone".
Compounded products should contain a list of active ingredients.
Exceptions could be made for standard items such as "Duke's
Mouthwash" or "Compounded Cafergot".
This rule is intended to meet a health need and is not meant as a punitive
measure. Board staff does expect pharmacies to be in compliance within
a reasonable time.
● If a controlled substance prescription is written in NC it must be
written by a practitioner licensed in NC. Answer: TRUE
● In the NC State FD&C by definition all written prescriptions must
contain the prescriber's DEA number. The executive directors of the key
administrative agencies (Pharmacy, Medical and Bureau of Narcotics
and Dangerous Drugs) agreed that prescriber's DEA number are only
required on prescriptions for controlled substances. (T/F?) Answer:
False. The State's FD&C Act - Agriculture Agency requires that all
written prescriptions have the prescriber's name, address, telephone
number and DEA number printed or stamped on the prescription
, ● According to NC Pharmacy Laws, a new prescription received
electronically must have:
A. The name of the pharamcy intended to recieve the transmittal
B. the telephone number of the transmitter's phone number for verbal
confirmation
C. the prescriber's signature
D. A & B
E. A, B &C Answer: E. An electronic signature of the prescriber is
acceptable
● The difference int he definition of "prescription" between the
Medicing and Allied Occupations (or pharmacy statutes) and the NC
Controlled Substance Act is the Medicine and Allies Occupations
requires the prescriber to be licensed in NC while the NC Controlled
Substance Act requires the prescriber authorized to prescribe. (T/F?)
Answer: False. The NC Controlles Substance Act requires that the
prescriber be licensed in NC. Her is and example where the more
stringent law is not followed. The NC BOP believes it would be very
difficult to determine if prescribers are licensed in NC especially for
pharmacies located on our boarders. For now, the BOP follows the
definition in the Medicine and Allies Occupations section... which is an
exception to the basic rule to follow the more stringent requirement
● In the NC Laws, the term "device" refers to "prescriptions devices"
only.
EXAM SCRIPT 2026 QUESTIONS AND
ANSWERS ALREADY PASSED
● May a pharmacy that services a nursing home install an automated
dispensing device (e.g., Pyxis) to dispense controlled substances at the
nursing home? Answer: In May 2005, the DEA promulgated a rule that
allows, where state law permits, a retail pharmacy to install an
automated dispensing system at a long term care facility. These systems
allow dispensing of single dosage controlled-substance units, and can
mitigate the problem of excess controlled-substance stocks and disposal.
Under Board rules, an automated dispensing device may only be
installed at a facility holding a pharmacy permit. It is the consensus of
the Board that limited service permits may be obtained for the
installation of automated dispensing systems in long term care facilities.
The DEA rule, found at 21 C.F.R. § 1301.17(c) and § 1301.27, provides
that, upon receiving authorization from appropriate state authorities, a
pharmacy may apply for an additional DEA registration to operate the
automated dispensing system at a long term care facility. Pharmacists
who serve long term care facilities are encouraged to investigate the use
of automated dispensing systems. The potential public health and safety
benefits are significant.
,● I would like to attend a Board meeting. When do Board meetings
occur? Answer: The Board of Pharmacy meets at 9 am the third Tuesday
of each month, except for August and December. If a meeting has to be
rescheduled, notice will appear on the Board's website.
● Is it permissible to compound domperidone? Answer: Domperidone
compounding is permissible only as part of an investigational new drug
application (IND). Domperidone is not a drug approved for human use
in the United States. Accordingly, any domperidone product dispensed in
the United States outside of an IND is unapproved, adulterated and
misbranded under both federal and North Carolina law. Notwithstanding
misleading Internet information to the contrary, it is not legal in the
United States to acquire, compound, dispense, or administer
domperidone outside of an IND. The FDA has long provided clear
guidance on this point, which may be found here:
http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm073
070.htm
● Has the FDA taken action against pharmacies that compound "bio-
identical hormone replacement" products? Answer: Yes
● Must a prescription label state the drug's generic name? Answer: Rule
.1818 provides that prescription labels shall contain the generic name of
the drug even if the brand name is in the container. The purpose of this
rule is to make it possible for hospital personnel to easily identify
products from the labels on prescription containers that may arrive with
,the patient in the emergency department. For example, a prescription for
Cordarone could be labeled as "Cordarone (Amiodarone)" if the brand
name was dispensed. If the generic was dispensed the label would only
need to contain the word "Amiodarone".
Compounded products should contain a list of active ingredients.
Exceptions could be made for standard items such as "Duke's
Mouthwash" or "Compounded Cafergot".
This rule is intended to meet a health need and is not meant as a punitive
measure. Board staff does expect pharmacies to be in compliance within
a reasonable time.
● If a controlled substance prescription is written in NC it must be
written by a practitioner licensed in NC. Answer: TRUE
● In the NC State FD&C by definition all written prescriptions must
contain the prescriber's DEA number. The executive directors of the key
administrative agencies (Pharmacy, Medical and Bureau of Narcotics
and Dangerous Drugs) agreed that prescriber's DEA number are only
required on prescriptions for controlled substances. (T/F?) Answer:
False. The State's FD&C Act - Agriculture Agency requires that all
written prescriptions have the prescriber's name, address, telephone
number and DEA number printed or stamped on the prescription
, ● According to NC Pharmacy Laws, a new prescription received
electronically must have:
A. The name of the pharamcy intended to recieve the transmittal
B. the telephone number of the transmitter's phone number for verbal
confirmation
C. the prescriber's signature
D. A & B
E. A, B &C Answer: E. An electronic signature of the prescriber is
acceptable
● The difference int he definition of "prescription" between the
Medicing and Allied Occupations (or pharmacy statutes) and the NC
Controlled Substance Act is the Medicine and Allies Occupations
requires the prescriber to be licensed in NC while the NC Controlled
Substance Act requires the prescriber authorized to prescribe. (T/F?)
Answer: False. The NC Controlles Substance Act requires that the
prescriber be licensed in NC. Her is and example where the more
stringent law is not followed. The NC BOP believes it would be very
difficult to determine if prescribers are licensed in NC especially for
pharmacies located on our boarders. For now, the BOP follows the
definition in the Medicine and Allies Occupations section... which is an
exception to the basic rule to follow the more stringent requirement
● In the NC Laws, the term "device" refers to "prescriptions devices"
only.
